In rare oncology research, access to high-quality, well-characterised human samples remains a critical challenge.
At Tebubio, we support your research by simplifying and securing sample sourcing through our global biobank network, ensuring compliance, traceability, and consistent quality, so you can stay focused on advancing discovery.
Learn how we facilitate access to rare cancer samples here.
Receive Fresh Human Pancreatic Islets Alerts
Receive Fresh Human Pancreatic Islets Alerts
Join our dedicated notification list to receive real-time alerts as soon as new, fresh human pancreatic islets lots become available, including essential donor details, purity, viability, and shipping schedules
Tebubio's CRO Services
Boost your diabetes research with Human Pancreatic Islets
Tebubio’s Glucose-stimulated Insulin Secretion (GSIS) services provide high-quality human islets and robust insulin secretion assays to accelerate your discovery of compounds impacting pancreatic β-cell function.
Product Highlights


|


LCI fluorescent probes for cell biology
Enhance live-cell imaging with advanced fluorescent probes: high specificity, low toxicity, and reliable signals for accurate, real-time insights.
Monthly Highlight
Gain full control over your stem cell culture environment
Highly active, animal-free cytokines and growth factors designed for defined, serum-free systems that deliver strong biological activity while supporting sustainable, scalable manufacturing.
- 100% animal-free production
- Endotoxin-free proteins
- High biological activity
- Reduced lot-to-lot variability
- Long shelf life and reliable performance
Knowledge Resources
Recorded Webinars


[Case Study] Tracking tools for mRNA research
-
mRNA production
-
LNP formulation
-
3D models
-
Q&A session with project managers


Development of TCR-T and CAR-T cells
-
New suite of tools supporting CAR-T and TCR-T cell R&D
-
Primary human immune cells
Stay Ahead in Your Research
Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in key research areas.






